XML 42 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Dec. 31, 2018
USD ($)
shares
Dec. 31, 2017
USD ($)
Jul. 01, 2018
Allowance for Doubtful Accounts Receivable, Ending Balance $ 0 $ 0  
Number of Operating Segments 3    
Allowance for Doubtful Accounts Receivable, Write-offs $ 7,320    
Write Off of Patent Costs 16,000    
Impairment of Long-Lived Assets Held-for-use 0    
Research and Development Expense, Total $ 32,591  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares 3,458,214    
Cash, FDIC Insured Amount $ 250,000    
Minimum [Member]      
Property, Plant and Equipment, Useful Life 2 years    
Minimum [Member] | Patents [Member]      
Finite-Lived Intangible Asset, Useful Life 15 years    
Maximum [Member]      
Property, Plant and Equipment, Useful Life 7 years    
Maximum [Member] | Patents [Member]      
Finite-Lived Intangible Asset, Useful Life 20 years    
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]      
Number of Major Customers 1 1  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | One Customer [Member]      
Concentration Risk, Percentage 50.00%    
ACTS Global Healthcare, Inc. [Member]      
Business Acquisition, Percentage of Voting Interests Acquired     100.00%